|Bid||164.60 x 0|
|Ask||177.00 x 0|
|Day's Range||164.80 - 165.40|
|52 Week Range||97.57 - 176.00|
|Beta (5Y Monthly)||0.45|
|PE Ratio (TTM)||8.21|
|Earnings Date||Sep 27, 2021 - Sep 30, 2021|
|Forward Dividend & Yield||0.38 (23.09%)|
|Ex-Dividend Date||Jun 01, 2021|
|1y Target Est||173.40|
Philip Morris (PM) secures more than 74% of Vectura's shares to become a majority stakeholder. The company expects to amplify growth in its Beyond Nicotine strategy via this move.
British inhaler developer Vectura has been barred from a major medical conference amid a growing backlash over its £1bn takeover by tobacco giant Philip Morris International.